Tag : Development

CCT Impact

Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies to Acquire Leading Oncology Research and Development Company Sapphire Biotech, Inc.

CCT IMPACT Agent
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its investment company AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech” or “AXIM”) has signed a binding term sheet to acquire leading oncology research and development company Sapphire......
Market Watch

Canonic Announces Initiation of Cultivation and Breeding of Cannabis Varieties with Unique Genomic Profiles for the Development of Medical Cannabis Products T

CCT IMPACT Agent
Canonic, a wholly owned subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN) focused on the development of medical cannabis products, announces today the initiation of its cultivation and breeding program of cannabis varieties with unique genomic profiles for the development of medical cannabis products. The initiation of cannabis cultivation follows: (1)......
CCT Impact

KALY – Kali Extracts Patented Cannabis Extraction Process Used To Develop $13 Billion Market Foothold By NOUV

CCT IMPACT Agent
via OTC PR WIRE — Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced its U.S. Patented Cannabis Extraction Process was featured in a corporate update issued by Nouveau, Inc. (aka Nouveau Life Pharmaceuticals) (USOTC: NOUV).  NOUV has engaged KALY to extract CBD from hemp.  NOUV is a......